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ABSTRACT
Positive syphilis serology was noted in 119
(0.49%) of the 24 053 pregnant women delivering
at St Orsola Hospital in Bologna, Italy, from
November 2000 through July 2007. Six presump-
tive cases of congenital syphilis with IgM western
blot positive results were found. Two infants had
a positive cerebrospinal ﬂuid (CSF) Venereal
Disease Research Laboratory test result (one also
had a positive CSF PCR result), another presented
long-bone lesions, and the remaining three were
preterm. These observations conﬁrmed that ante-
natal syphilis screening facilitates treatment dur-
ing pregnancy and offsets vertical transmission;
moreover, the use of IgM western blot and careful
CSF examination allowed the identiﬁcation and
treatment of high-risk newborns.
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In 1998, the WHO estimated that one million
pregnancies each year worldwide were adversely
affected by syphilis due to maternal infection [1].
Congenital syphilis (CS) is mainly a consequence
of the lack of antenatal care and control of sexually
transmitted infections [2]. The foundation of the
prevention of CS is the diagnosis of syphilis by
serological screening during pregnancy [3]. Cur-
rent Italian guidelines suggest that all pregnant
women should be tested in the ﬁrst trimester [4].
Several factors contribute to the different manifes-
tations of CS, and even asymptomatic newborns
may have early or late postnatal manifestations [5].
Owing to the frequent absence of speciﬁc signs of
infection at birth, serological tests are often the
only means of acquiring a correct CS diagnosis.
As immunoglobulins G (IgGs) easily cross the
placenta during pregnancy, Treponema pallidum-
speciﬁc IgG detection in infants’ sera at birth does
not allow detection of high-risk newborns.
The aim of this study was to evaluate the
usefulness of T. pallidum IgM western blot (WB)
and cerebrospinal ﬂuid (CSF) PCR as an aid in the
diagnosis of CS during a prospective surveillance
study carried out at St Orsola Hospital in Bologna,
Italy from November 2000 through July 2007.
All women were screened during pregnancy
and at delivery for syphilis by one of the follow-
ing commercial methods: Syphilis Screening
Recombinant EIA (Radim, Pomezia, Italy), LIAI-
SON Treponema Screen (Diasorin, Saluggia,
Italy) [6], or ARCHITECT Syphilis TP (Abbott
Japan Co., Tokyo, Japan).
Positive samples were further analysed by
T. pallidum haemagglutination assay (AlfaWass-
erman, Milan, Italy) and an in-house WB [7]; if
positive results were conﬁrmed, the rapid plasma
reagin (RPR) test (Radim, Pomezia, Italy) was also
performed.
Amaternal case history was obtained in order to
identify high-risk pregnancies. Infants born to
syphilis-seropositive mothers were enrolled in a
prospective follow-up. Tests were performed at
birth (including IgMWB). The sourcewas determi-
ned, and propagation and extraction of T. pallidum
subsp. Nichols strain for WB were performed as
previously reported [8,9]. Infants with positive
RPR test results at birth, born to mothers not
adequately treated, also received long-bone radio-
graphy as well as CSF analysis, when possible,
including Venereal Disease Research Laboratory
testing (DadeBehring,Marburg,Germany). Since 1
January 2006, all CSF samples have been also anal-
ysed by a PCRmethod, as follows. DNA extraction
was performed with the QIAamp DNA Mini-kit
(Qiagen GmbH, Hilden, Germany) in 400 lL of
CSF samples. PCRwas performed by using a set of
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primers [10] amplifying a fragment of the T. palli-
dum DNA polymerase I gene. This primer set
generated an ampliﬁcation product of 377 bp. All
ampliﬁcations were carried out with Eppendorf
Mastercycler Personal (Eppendorf, AG.,Hamburg,
Germany). The ampliconswere electrophoresedon
Fig. 1. (a) Syphilis serology in pregnant women and the outcome of their newborns. (b) Distribution of maternal
characteristics of 114 ⁄ 119 women seropositivefor syphilis. Data regarding the remaining ﬁve women (four from eastern
Europe and one from South America) are not available, as their babies were put up for adoption. Numbers of women are
indicated in boxes.
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a 1.5% agarose gel at 100 V for 1 h and visualized
after staining with SYBR safeTM (Invitrogen Co.,
Carlsbad, CA, USA). All seroreactive infants
received careful follow-up examinations and
serological testing at 0, 3, 6, 9 and 12 months or
until the test results became negative.
During the study period, 24 053 women deliv-
ered 24 447 infants. Serological evidence of syph-
ilis at delivery was found in 119 women giving
birth to 133 children (Fig. 1). The overall syphilis
seroprevalence in pregnant women was 0.49%.
Sixty women had already been adequately
treated before pregnancy, 12 were advised to
repeat therapy during pregnancy because of
persistent high-titre RPR which later decreased
four-fold, and 37 received the ﬁrst syphilis diag-
nosis during pregnancy: the last category of
patients were immediately treated with intramus-
cular benzathine penicillin, and their RPR titres
showed a four-fold decrease by the end of the
pregnancy. Finally, ten women, classiﬁed as latent
syphilis patients [11], were ﬁrst found to have
reactive test results for syphilis at delivery,
having received inadequate prenatal care. Six of
the ten infants born to untreated mothers had
positive IgM WB and RPR test results at birth
(Table 1). Three infants were preterm (two ⁄ three
with extremely low birthweight). The remaining
three were born at term; two had positive CSF
Venereal Disease Research Laboratory test results
(one of whom also had a positive CSF PCR result),
and the third infant presented long-bone lesions
upon X-ray examination (trasversal streaks of
radioparency about femoral distal metaphyses),
which were no longer evident after therapy. All
six infants were hospitalized for treatment with
intravenous penicillin G (50 000 U ⁄ kg ⁄dose every
8–12 h) for 14 days. The remaining four infants
born to mothers who received the ﬁrst syphilis
diagnosis at delivery had negative or weakly
positive RPR test results and negative IgM WB
test results at birth. The long-bone X-ray exami-
nation and CSF analysis results were normal
(Table 1). These infants, who were presumptively
uninfected, received only a single dose of intra-
muscular benzathine penicillin (50 000 units ⁄kg).
Finally, 123 asymptomatic infants were born to
the 109 mothers adequately treated before or
during pregnancy; none of these presented clin-
ical or laboratory evidence of syphilis infection.
No positive IgM WB result was found in this
group of infants.
The most important risk factor for congenital
syphilis is inadequate prenatal care or the absence
of care [12–18]. In this study, none of the six
infants with presumptive congenital disease had
evident clinical signs at birth. Therefore, CS could
have been misdiagnosed if serological tests had
not been performed at the time of delivery for
both mother and newborn. Prematurity was the
only non-speciﬁc clinical manifestation. Although
the aetiology of prematurity among high-risk
pregnant women varies, CS is a well-documented
cause [16,19].
Table 1. Characteristics of untreated mothers who were seropositive for syphilis and of their infants at delivery and at last
follow-up examination
Maternal proﬁle Infants’ characteristics at birth
Infants’ characteristics
at last follow-up
examination
Nationality
Time of
residence in
Italy before
pregnancy (years)
Marital
status ⁄husband’s
nationality
GA
(weeks)
BW
(g)
IgM
WB RPR
VDRL
CSF PolA PCR
Long-bone
X-ray
Age
(months) RPR TPHA
Case 1 Romania 1 Unmarried 24 695 + + NDa Not done Normal 10 ) +
Case 2 Romania 4 Married ⁄ Italian 26 495 + + NDa Not done Normal 12 ) +
Case 3 Romania 1 Unmarried 34 2150 + + ) Not done Normal 4 (lost)? + +
Case 4 Russia 2 Married ⁄ Italian 40 3660 + + + Not done Normal 10 ) +
Case 5 Ukraine 1 Unmarried 39 3250 + + + + Normal 24 ) +
Case 6 Romania 1 Married ⁄Rumanian 38 2800 + + ) Not done Abnormal 12 ) +
Case 7 Cuba 2 Married ⁄ Italian 40 3400 ) ) ) Not done Normal 12 ) )
Case 8 Moldavia 6 Married ⁄ Italian 39 3300 ) + ) ) Normal 9 ) )
Case 9 Romania 1 Unmarried 40 3250 ) + ) ) Normal 6 ) )
Case 10 Moldavia 1 Unmarried 38 2890 ) + ) ) Normal 9 ) )
GA, gestational age; BW, bodyweight; WB, western blot; RPR, rapid plasma reagin; VDRL, Venereal Disease Research Laboratory; CSF, cerebrospinal ﬂuid; TPHA, Treponema
pallidum haemagglutination assay.
The ﬁrst six infants were presumptive cases of congenital syphilis, whereas the remaining four were uninfected. The ten mothers with inadequate prenatal care were born in
foreign countries, but all had been in Italy for at least 1 year (range: 1–6 years) before the pregnancy and four or ten had married Italian citizens. All six infants with congenital
syphilis were born to mothers coming from eastern Europe.
aCSF was not drawn because it was contraindicated due to the very low birthweight of these infants.
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Results obtained by the use of IgM WB,
combined with a careful CSF examination includ-
ing PolA PCR, allowed paediatricians to identify
high-risk infants for prompt and adequate treat-
ment, thus avoiding unnecessary therapy and the
consequent hospitalization of uninfected infants.
Although, in Italy, prenatal screening for syph-
ilis is scheduled during the ﬁrst trimester of
pregnancy, women are not consistently advised to
seek serological syphilis testing during their
pregnancies, as already observed [19]. Therefore,
the economic rationale in the study area is to test
women at delivery to prevent CS; results obtained
by an accurate serological examination of mother-
infant pair samples allowed the pediatricians to
identify high risk infants and to promptly and
adequately treat these cases, avoiding unneces-
sary thereapy and the consequent hospitalization
of uninfected infants [20]. Moreover, it is advis-
able that gynaecologists more closely control
foreign women during pregnancy, including the
use of serological tests for syphilis, which is a
re-emerging problem in the study area [19].
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